Publication Spotlight

Rebecca Kirch in Cancer

"By encouraging stakeholders to self‐identify with a shared mission of improving the quality of life among patients who are receiving or have received adjuvant therapy, new collaborations, synergies, and patient benefits may be realized, even in the absence of formal program structures and agreements," she writes with her co-authors. For more information about stakeholder perspectives on addressing adverse events from adjuvant cancer therapy, click the link below.